Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: Implication for a trachoma transmission- blocking vaccine

Journal of Immunology

Volumn 182, Issue 12, 2009, Pages 8063-8070

  Kari, Laszlo ^a   Whitmire, William M ^a   Crane, Deborah D ^a   Reveneau, Nathalie ^a,c   Carlson, John H ^a   Goheen, Morgan M ^a   Peterson, Ellena M ^b   Pal, Sukumar ^b   De La Maza, Luis M ^b   Caldwell, Harlan D ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Sanofi Pasteur   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 4; OUTER MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR ALPHA; BACTERIUM ANTIBODY; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL IMMUNITY; BACTERIAL STRAIN; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; CROSS REACTION; CYTOKINE RELEASE; DISEASE DURATION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL INFECTION; EYE DISEASE; FEMALE; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOGENICITY; MACACA; MALE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; TRACHOMA; ANIMAL; BLOOD; CHLAMYDIASIS; DISEASE MODEL; DISEASE TRANSMISSION; HELA CELL; IMMUNOLOGY; KINETICS; LEUKOCYTE; PATHOLOGY; PROTEIN DENATURATION; SECRETION; TITRIMETRY;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HELA CELLS; HUMANS; KINETICS; LEUKOCYTES; MACACA FASCICULARIS; MALE; PROTEIN DENATURATION; TITRIMETRY;

EID: 67649201737     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0804375     Document Type: Article

References (48)

1. Resnikoff, S., D. Pascolini, D. Etya'ale, I. Kocur, R. Pararajasegaram, G. P. Pokharel, and S. P. Mariotti. 2004. Global data on visual impairment in the year 2002. Bull. World Health Organ. 82: 844-851.
2. WHO. 1998. Global elimination of blinding trachoma. Resolution WHA 51.11 adopted by the World Health Assembly 16 May 1998.
3. Grayston, J. T., and S. Wang. 1975. New knowledge of chlamydiae and the diseases they cause. J. Infect. Dis. 132: 87-105.
4. Schachter, J. 1978. Chlamydial infections (Part 1). N. Engl. J. Med. 298: 428-434.
5. Schachter, J. 1978. Chlamydial infections (Part 3). N. Engl. J. Med. 298: 540-549.
6. Schachter, J. 1978. Chlamydial infections (Part 2). N. Engl. J. Med. 298: 490-495.
7. Moulder, J. W. 1982. The relation of basic biology to pathogenic potential in the genus Chlamydia. Infection 10(Suppl. 1): S10-S18.
8. Caldwell, H. D., and L. J. Perry. 1982. Neutralization of Chlamydia trachomatis infectivity with antibodies to the major outer membrane protein. Infect. Immun. 38: 745-754.
9. Peeling, R. W., and R. C. Brunham. 1991. Neutralization of Chlamydia trachomatis: kinetics and stoichiometry. Infect. Immun. 59: 2624-2630.
10. Zhang, Y. X., S. Stewart, T. Joseph, H. R. Taylor, and H. D. Caldwell. 1987. Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis. J. Immunol. 138: 575-581.
11. de la Maza, M. A., and L. M. de la Maza. 1995. A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections. Vaccine 13: 119-127.
12. Ward, M. E., G. M. Webber, and A. K. Shahani. 1986. Computer modelling of trachoma control strategies. In Chlamydial Infections. D. Oriel, G. Ridgway, J. Schachter, D. Taylor-Robinson, and M. Ward, eds. Cambridge University Press, Cambridge, pp. 154-157.
13. Grayston, J. T., S. P. Wang, L. J. Yeh, and C. C. Kuo. 1985. Importance of reinfection in the pathogenesis of trachoma. Rev. Infect. Dis. 7: 717-725.
14. Nichols, R. L., S. D. Bell, Jr., N. A. Haddad, and A. A. Bobb. 1969. Studies on trachoma. VI. Microbiological observations in a field trial in Saudi Arabia of bivalent trachoma vaccine at three dosage levels. Am. J. Trop. Med. Hyg. 18: 723-730.
15. Woolridge, R. L., J. T. Grayston, I. H. Chang, K. H. Cheng, C. Y. Yang, and C. Neave. 1967. Field trial of a monovalent and of a bivalent mineral oil adjuvant trachoma vaccine in Taiwan school children. Am. J. Ophthalmol. 63(Suppl): 1645-1650.
16. Murdin, A. D., H. Su, D. S. Manning, M. H. Klein, M. J. Parnell, and H. D. Caldwell. 1993. A poliovirus hybrid expressing a neutralization epitope from the major outer membrane protein of Chlamydia trachomatis is highly immunogenic. Infect. Immun. 61: 4406-4414.
17. Peterson, E. M., X. Cheng, B. A. Markoff, T. J. Fielder, and L. M. de la Maza. 1991. Functional and structural mapping of Chlamydia trachomatis species-specific major outer membrane protein epitopes by use of neutralizing monoclonal antibodies. Infect. Immun. 59: 4147-4153.
18. Peterson, E. M., X. Cheng, S. Pal, and L. M. de la Maza. 1993. Effects of antibody isotype and host cell type on in vitro neutralization of Chlamydia trachomatis. Infect. Immun. 61: 498-503.
19. Su, H., R. P. Morrison, N. G. Watkins, and H. D. Caldwell. 1990. Identification and characterization of T helper cell epitopes of the major outer membrane protein of Chlamydia trachomatis. J. Exp. Med. 172: 203-212. (Pubitemid 20217261)
20. Su, H., and H. D. Caldwell. 1992. Immunogenicity of a chimeric peptide corresponding to T helper and B cell epitopes of the Chlamydia trachomatis major outer membrane protein. J. Exp. Med. 175: 227-235.
21. Toye, B., G. M. Zhong, R. Peeling, and R. C. Brunham. 1990. Immunologic characterization of a cloned fragment containing the species-specific epitope from the major outer membrane protein of Chlamydia trachomatis. Infect. Immun. 58: 3909-3913.
22. Stephens, R. S., G. Mullenbach, R. Sanchez-Pescador, and N. Agabian. 1986. Sequence analysis of the major outer membrane protein gene from Chlamydia trachomatis serovar L2. J Bacteriol. 168: 1277-1282. (Pubitemid 17226815)
23. Stephens, R. S., R. Sanchez-Pescador, E. A. Wagar, C. Inouye, and M. S. Urdea. 1987. Diversity of Chlamydia trachomatis major outer membrane protein genes. J. Bacteriol. 169: 3879-3885.
24. Kim, S. K., and R. DeMars. 2001. Epitope clusters in the major outer membrane protein of Chlamydia trachomatis. Curr. Opin. Immunol. 13: 429-426.
25. Stephens, R. S., E. A. Wagar, and G. K. Schoolnik. 1988. High-resolution mapping of serovar-specific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis. J. Exp. Med. 167: 817-831.
26. Baehr, W., Y. X. Zhang, T. Joseph, H. Su, F. E. Nano, K. D. Everett, and H. D. Caldwell. 1988. Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes. Proc. Natl. Acad. Sci. USA 85: 4000-4004.
27. Berry, L. J., D. K. Hickey, K. A. Skelding, S. Bao, A. M. Rendina, P. M. Hansbro, C. M. Gockel, and K. W. Beagley. 2004. Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection. Infect. Immun. 72: 1019-1028.
28. Dong-Ji, Z., X. Yang, C. Shen, H. Lu, A. Murdin, and R. C. Brunham. 2000. Priming with Chlamydia trachomatis major outer membrane protein (MOMP) DNA followed by MOMP ISCOM boosting enhances protection and is associated with increased immunoglobulin A and Th1 cellular immune responses. Infect. Immun. 68: 3074-3078.
29. Pal, S., I. Theodor, E. M. Peterson, and L. M. de la Maza. 1997. Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge. Infect. Immun. 65: 3361-3369.
30. Pal, S., K. M. Barnhart, Q. Wei, A. M. Abai, E. M. Peterson, and L. M. de la Maza. 1999. Vaccination of mice with DNA plasmids coding for the Chlamydia trachomatis major outer membrane protein elicits an immune response but fails to protect against a genital challenge. Vaccine 17: 459-465.
31. Shaw, A. C., K. Gevaert, H. Demol, B. Hoorelbeke, J. Vandekerckhove, M. R. Larsen, P. Roepstorff, A. Holm, G. Christiansen, and S. Birkelund. 2002. Comparative proteome analysis of Chlamydia trachomatis serovar A, D and L2. Proteomics 2: 164-186.
32. Zhang, D. J., X. Yang, C. Shen, and R. C. Brunham. 1999. Characterization of immune responses following intramuscular DNA immunization with the MOMP gene of Chlamydia trachomatis mouse pneumonitis strain. Immunology 96: 314-321.
33. Campos, M., S. Pal, T. P. O'Brien, H. R. Taylor, R. A. Prendergast, and J. A. Whittum-Hudson. 1995. A chlamydial major outer membrane protein extract as a trachoma vaccine candidate. Invest. Ophthalmol. Vis. Sci. 36: 1477-1491.
34. Taylor, H. R., J. Whittum-Hudson, J. Schachter, H. D. Caldwell, and R. A. Prendergast. 1988. Oral immunization with chlamydial major outer membrane protein (MOMP). Invest. Ophthalmol. Vis. Sci. 29: 1847-1853.
35. Pal, S., E. M. Peterson, and L. M. de la Maza. 2005. Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune reponse as protective as that resulting from inoculation with live bacteria. Infect. Immun. 73: 8153-8160.
36. Taylor, H. R., R. A. Prendergast, C. R. Dawson, J. Schachter, and A. M. Silverstein. 1981. An animal model for cicatrizing trachoma. Invest. Ophthalmol. Vis. Sci. 21: 422-433.
37. Su, H., N. G. Watkins, Y. X. Zhang, and H. D. Caldwell. 1990. Chlamydia trachomatis-host cell interactions: role of the chlamydial major outer membrane protein as an adhesin. Infect. Immun. 58: 1017-1025. (Pubitemid 20117034)
38. Taylor, G. R., K. Hyde, R. T. Wensley, and I. W. Delamore. 1988. Polymerase chain-reaction amplification and detection of HIV DNA-sequences in the peripheral-blood. Br. J. Haematol. 69: 127.
39. Dawson, C., T. R. Wood, L. Rose, and L. Hanna. 1967. Experimental inclusion conjunctivitis in man. 3. Keratitis and other complications. Arch. Ophthalmol. 78: 341-349.
40. Tarizzo, M. L., R. Nataf, and B. Nabli. 1967. Experimental inoculation of thirteen volunteers with agent isolated from inclusion conjunctivitis. Am. J. Ophthalmol. 63: 1120-1128.
41. Taylor, H. R. 1990. Development of immunity to ocular chlamydial infection. Am. J. Trop. Med. Hyg. 42: 358-364.
42. Kari, L., W. M. Whitmire, J. H. Carlson, D. D. Crane, N. Reveneau, D. E. Nelson, D. C. Mabey, R. L. Bailey, M. J. Holland, G. McClarty, and H. D. Caldwell. 2008. Pathogenic diversity among Chlamydia trachomatis ocular strains in non-human primates is affected by subtle genomic variations. J. Infect. Dis. 197: 449-456.
43. Rodríguez-Marañón, M. J., R. M. Bush, E. M. Peterson, T. Schirmer, and L. M. de la Maza. 2002. Prediction of the membrane-spanning β-strands of the major outer membrane protein of Chlamydia. Protein Sci. 11: 1854-1861.
44. Taylor, H. R., S. L. Johnson, R. A. Prendergast, J. Schachter, C. R. Dawson, and A. M. Silverstein. 1982. An animal model of trachoma. II. The importance of repeated reinfection. Invest. Ophthalmol. Vis. Sci. 23: 507-515. (Pubitemid 12000565)
45. Broman, A. T., K. Shum, B. Munoz, D. D. Duncan, and S. K. West. 2006. Spatial clustering of ocular chlamydial infection over time following treatment among households in a village in Tanzania. Invest. Opthalmol. Vis. Sci. 47: 99-104.
46. Chidambaram, J. D., W. Alemayehu, M. Melese, T. Lakew, E. Yi, J. House, V. Cevallos, Z. Zhou, K. Maxey, D. C. Lee, et al. 2006. Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma. JAMA 295: 1142-1146.
47. Leitman, T., T. Porco, C. Dawson, and S. Blower. 1999. Global elimination of trachoma: how frequently should we administer mass chemotherapy? Nat. Med. 5: 572-576.
48. West, S. K., B. Munoz, H. Mkocha, M. J. Holland, A. Aguirre, A. W. Solomon, A. Foster, R. L. Bailey, and D. C. Mabey. 2005. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. Lancet 366: 1296-1300.